Skip to main content
HLN
NYSE Industrial Applications And Services

Haleon Q3 Organic Growth Misses at +2.6%; FY Guidance Cut to ~2.5%, Adds £500M Buyback

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Pharmaceutical Stocks · Healthcare
Sentiment info
Negative
Importance info
7
Price
$8.549
Mkt Cap
$43.815B
52W Low
$8.65
52W High
$11.28
52W Position info
1.2% below low
Off High info
24% below high
Rel. Volume info
1.5× avg
Market data snapshot near publication time

HLN is trading near its 52-week low of $8.65 (1.2% below the low).

Summary

Haleon posted Q3 organic revenue growth of 2.6%, below expectations, and cut FY2026 organic growth guidance to around 2.5%. It kept high-single digit profit growth and added £500m to its buyback.


Key Events · Earnings and Guidance · HLN

  • Q3 Organic Growth Below Expectations

    Q3 organic revenue growth was +2.6% on £2,868m reported revenue, split +2.1% price and +0.5% volume/mix. Soft cold and flu consumption and lower North America orders held it back.

  • FY2026 Guidance Cut to ~2.5%

    Full-year organic revenue growth is now expected to be around 2.5%, while adjusted operating profit growth is still guided to high-single digit at constant currency.

  • China Centrum Import Halt

    A raw material classification change forced a stop to imports of Centrum OTC-registered products in China until further notice; that business generated c.£75m of revenue in FY2025. The company says it is not a quality or safety issue.

  • Brazil Model Change Costs Q4 Revenue

    The go-to-market overhaul in Brazil is being pulled forward into Q4 2026, expected to cost c.£15-20m of net revenue in the quarter.


Analysis · HLN · Industrial Applications And Services

The guidance cut is the fact that matters most here, with the stock already trading near its 52-week low. Haleon's third quarter came in below its own expectations: organic revenue grew 2.6%, with price contributing 2.1 points and volume/mix only 0.5, and management cut full-year organic growth guidance to around 2.5%. Two specific drags are quantified — a raw material classification change that halted imports of Centrum OTC-registered products into China (a business that generated c.£75m of revenue in FY2025) and an accelerated Brazil go-to-market change costing c.£15-20m of Q4 net revenue. Against that, adjusted operating profit is still guided to high-single digit growth at constant currency, and the company allocated a further £500m to buybacks, which supports the share price while growth is soft.

How filings like this one have moved

In the 30 days to Nov 12, 2026, 37% of the 3595 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, HLN was trading at $8.55 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $43.8B. The 52-week trading range was $8.65 to $11.28. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

HLN - Latest Insights

HLN
Oct 29, 2026, 10:13 AM EDT
Source: Benzinga
Importance Score:
9
Price at Filing: $8.43
Real-time Price: $9.17 info
Change: +$0.745 (+9%) info
Market Cap: $40.053B info
HLN
Jul 30, 2026, 12:14 PM EDT
Filing Type: 6-K
Importance Score:
7
Price at Filing: $10.03
Real-time Price: $9.17 info
Change: -$0.860 (-9%) info
Market Cap: $40.053B info
HLN
Jul 30, 2026, 7:00 AM EDT
Filing Type: 6-K
Importance Score:
7
Price at Filing: $9.97
Real-time Price: $9.17 info
Change: -$0.7999 (-8%) info
Market Cap: $40.053B info
HLN
Jun 29, 2026, 6:22 AM EDT
Filing Type: 6-K
Importance Score:
7
Price at Filing: $9.26
Real-time Price: $9.17 info
Change: -$0.090 (-0.97%) info
Market Cap: $40.053B info
HLN
Jun 22, 2026, 6:42 AM EDT
Filing Type: 6-K
Importance Score:
7
Price at Filing: $8.84
Real-time Price: $9.17 info
Change: +$0.330 (+4%) info
Market Cap: $40.053B info